MaxCyte director granted RSUs and stock options
MAXCYTE, INC. director Yasir B. Al-Wakeel received equity awards as part of his annual non-employee director compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MAXCYTE, INC. director Yasir B. Al-Wakeel received equity awards as part of his annual non-employee director compensation. He was granted 30,421 shares of Common Stock in the form of restricted stock units, plus stock options for 49,579 shares at an exercise price of $1.13 per share.
The RSUs and option grant were made under the company’s Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, contingent on his continued service. Following the RSU grant, he directly owns 80,998 shares of Common Stock.
Insider Trade Summary
Grant/Award: 80,000 shares
Grant/Award
2 txns
Insider
Al-Wakeel Yasir B.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 49,579 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 30,421 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 49,579 contracts (Direct);
Common Stock — 80,998 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date.
Key Figures
RSU grant: 30,421 shares
Option grant size: 49,579 options
Option exercise price: $1.13 per share
+3 more
6 metrics
RSU grant
30,421 shares
Restricted stock units representing Common Stock
Option grant size
49,579 options
Stock options over Common Stock
Option exercise price
$1.13 per share
Conversion/exercise price for 49,579 options
Shares held after RSU grant
80,998 shares
Direct Common Stock ownership following RSU grant
Vesting date
June 17, 2027
Vesting of shares underlying annual director grant
Option expiration
June 16, 2036
Expiration date of stock options granted
Key Terms
restricted stock units ("RSUs"), Equity Grant Policy, non-employee directors, vesting
4 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Equity Grant Policy financial
"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors."
non-employee directors financial
"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
vesting financial
"The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did MaxCyte (MXCT) director Yasir B. Al-Wakeel receive?
Yasir B. Al-Wakeel received 30,421 restricted stock units and stock options for 49,579 shares of MaxCyte Common Stock. These awards represent annual compensation under the company’s Equity Grant Policy for non-employee directors, rather than open-market share purchases.
What is the exercise price of the new MaxCyte (MXCT) stock options?
The stock options granted to Yasir B. Al-Wakeel have an exercise price of $1.13 per share. They cover 49,579 shares of MaxCyte Common Stock and were issued as part of his annual non-employee director equity compensation grant.
When do Yasir B. Al-Wakeel’s MaxCyte (MXCT) RSUs and options vest?
The shares underlying the annual equity grant vest on June 17, 2027, subject to Yasir B. Al-Wakeel’s continuous service as a director. Both the restricted stock units and related option grant follow MaxCyte’s Equity Grant Policy for non-employee directors.
Is Yasir B. Al-Wakeel’s MaxCyte (MXCT) Form 4 a market purchase or a compensation grant?
The Form 4 reflects compensation grants, not a market purchase. It reports 30,421 restricted stock units and options for 49,579 shares awarded at no cost under MaxCyte’s Equity Grant Policy for non-employee directors, contingent on continued board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates